| Product Code: ETC7549639 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Shubham Padhi | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The India opioid receptor agonist market import shipment demonstrated significant growth momentum with a CAGR of 8.9% from 2020 to 2024. Notably, the growth rate spiked by 53.6% between 2023 and 2024, indicating a substantial expansion trend over the years, showcasing a thriving market.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 India Opioid Receptor Agonist Market Overview |
3.1 India Country Macro Economic Indicators |
3.2 India Opioid Receptor Agonist Market Revenues & Volume, 2021 & 2031F |
3.3 India Opioid Receptor Agonist Market - Industry Life Cycle |
3.4 India Opioid Receptor Agonist Market - Porter's Five Forces |
3.5 India Opioid Receptor Agonist Market Revenues & Volume Share, By Drugs, 2021 & 2031F |
3.6 India Opioid Receptor Agonist Market Revenues & Volume Share, By Receptor Binding, 2021 & 2031F |
3.7 India Opioid Receptor Agonist Market Revenues & Volume Share, By Indication, 2021 & 2031F |
3.8 India Opioid Receptor Agonist Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.9 India Opioid Receptor Agonist Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
3.10 India Opioid Receptor Agonist Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 India Opioid Receptor Agonist Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of chronic pain conditions in India |
4.2.2 Growing awareness and acceptance of opioid drugs for pain management |
4.2.3 Rise in healthcare expenditure and investments in pain management therapies |
4.3 Market Restraints |
4.3.1 Stringent regulations and restrictions on opioid medications in India |
4.3.2 Concerns regarding potential misuse and addiction to opioid drugs |
4.3.3 Limited availability and accessibility of opioid medications in certain regions of India |
5 India Opioid Receptor Agonist Market Trends |
6 India Opioid Receptor Agonist Market, By Types |
6.1 India Opioid Receptor Agonist Market, By Drugs |
6.1.1 Overview and Analysis |
6.1.2 India Opioid Receptor Agonist Market Revenues & Volume, By Drugs, 2021- 2031F |
6.1.3 India Opioid Receptor Agonist Market Revenues & Volume, By Fentanyl, 2021- 2031F |
6.1.4 India Opioid Receptor Agonist Market Revenues & Volume, By Codeine, 2021- 2031F |
6.1.5 India Opioid Receptor Agonist Market Revenues & Volume, By Morphine, 2021- 2031F |
6.1.6 India Opioid Receptor Agonist Market Revenues & Volume, By Buprenorphine, 2021- 2031F |
6.1.7 India Opioid Receptor Agonist Market Revenues & Volume, By Others, 2021- 2031F |
6.2 India Opioid Receptor Agonist Market, By Receptor Binding |
6.2.1 Overview and Analysis |
6.2.2 India Opioid Receptor Agonist Market Revenues & Volume, By Full Agonist, 2021- 2031F |
6.2.3 India Opioid Receptor Agonist Market Revenues & Volume, By Partial Agonist, 2021- 2031F |
6.3 India Opioid Receptor Agonist Market, By Indication |
6.3.1 Overview and Analysis |
6.3.2 India Opioid Receptor Agonist Market Revenues & Volume, By Pain management, 2021- 2031F |
6.3.3 India Opioid Receptor Agonist Market Revenues & Volume, By Cough Suppression, 2021- 2031F |
6.3.4 India Opioid Receptor Agonist Market Revenues & Volume, By Diarrhoea suppression, 2021- 2031F |
6.3.5 India Opioid Receptor Agonist Market Revenues & Volume, By Others, 2021- 2031F |
6.4 India Opioid Receptor Agonist Market, By Route of Administration |
6.4.1 Overview and Analysis |
6.4.2 India Opioid Receptor Agonist Market Revenues & Volume, By Intravenous, 2021- 2031F |
6.4.3 India Opioid Receptor Agonist Market Revenues & Volume, By Subcutaneous, 2021- 2031F |
6.4.4 India Opioid Receptor Agonist Market Revenues & Volume, By Others, 2021- 2031F |
6.5 India Opioid Receptor Agonist Market, By End-Users |
6.5.1 Overview and Analysis |
6.5.2 India Opioid Receptor Agonist Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.5.3 India Opioid Receptor Agonist Market Revenues & Volume, By Homecare, 2021- 2031F |
6.5.4 India Opioid Receptor Agonist Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.5.5 India Opioid Receptor Agonist Market Revenues & Volume, By Others, 2021- 2031F |
6.6 India Opioid Receptor Agonist Market, By Distribution Channel |
6.6.1 Overview and Analysis |
6.6.2 India Opioid Receptor Agonist Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.6.3 India Opioid Receptor Agonist Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
6.6.4 India Opioid Receptor Agonist Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
7 India Opioid Receptor Agonist Market Import-Export Trade Statistics |
7.1 India Opioid Receptor Agonist Market Export to Major Countries |
7.2 India Opioid Receptor Agonist Market Imports from Major Countries |
8 India Opioid Receptor Agonist Market Key Performance Indicators |
8.1 Number of new opioid drug approvals by regulatory authorities in India |
8.2 Percentage of healthcare professionals trained in appropriate opioid prescribing practices |
8.3 Patient satisfaction scores related to pain management efficacy with opioid medications |
8.4 Number of pain clinics or specialized centers offering opioid therapy in India |
8.5 Rate of adverse events or misuse associated with opioid medications in India |
9 India Opioid Receptor Agonist Market - Opportunity Assessment |
9.1 India Opioid Receptor Agonist Market Opportunity Assessment, By Drugs, 2021 & 2031F |
9.2 India Opioid Receptor Agonist Market Opportunity Assessment, By Receptor Binding, 2021 & 2031F |
9.3 India Opioid Receptor Agonist Market Opportunity Assessment, By Indication, 2021 & 2031F |
9.4 India Opioid Receptor Agonist Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.5 India Opioid Receptor Agonist Market Opportunity Assessment, By End-Users, 2021 & 2031F |
9.6 India Opioid Receptor Agonist Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 India Opioid Receptor Agonist Market - Competitive Landscape |
10.1 India Opioid Receptor Agonist Market Revenue Share, By Companies, 2024 |
10.2 India Opioid Receptor Agonist Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here